1000 Participants Needed

Postcoital Sponge for Vaginal Health

Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Atlantic Health System
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.

Eligibility Criteria

This trial is for individuals experiencing sexual dysfunction, vaginal infections, bacterial vaginosis, or unusual vaginal discharge. Participants should be interested in testing a postcoital sponge designed to absorb semen and potentially reduce symptoms like odor and discharge after sex.

Inclusion Criteria

I am over 18 years old.
I am sexually active with men.
Resides in continental USA
See 2 more

Exclusion Criteria

Currently pregnant or trying to conceive
I have difficulty using devices due to poor hand movement.
I am unable to understand or sign the consent form.

Treatment Details

Interventions

  • LiviWell Postcoital Vaginal Insert
Trial OverviewThe LiviWell Postcoital Vaginal Insert is being tested for its effectiveness in absorbing semen after intercourse and improving symptoms related to the vaginal microbiome disruption such as odor and discharge.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: pH subsetExperimental Treatment1 Intervention
This subset of patients (n=100) will be checking their vaginal pH at various time intervals (before, 2-6 hours after, and 10-14 hours after sex).
Group II: Main CohortExperimental Treatment1 Intervention
This subset of patients (n=900) will be providing user feedback on the study device, and will not be checking their vaginal pH

Find a Clinic Near You

Who Is Running the Clinical Trial?

Atlantic Health System

Lead Sponsor

Trials
58
Recruited
9,400+